Elmira Daily

The increasing incidence of prostate cancer especially among aging men is the key driver of the global “transrectal ultrasound market”. This was found by Fortune Business Insights in a report, titled “Transrectal Ultrasound Market Size, Share and Global Trend by Product (Systems, Transducers), Type (Cart/Trolley Based, Portable), Application (Diagnostic, Image-guided Treatment), End User (Diagnostic Laboratories, Hospitals) and Geography Forecast till 2025”. Fortune Business Insights predicts the global Market to exhibit a CAGR of 4.5% during the forecast period. Furthermore, in 2017, the market was valued at US$ 204.8 and is anticipated to reach US$ 291.2 Mn by the end of 2025.

Among regions, Asia Pacific is likely to offer lucrative growth opportunities to the enterprises operating in the global market. The huge installed bases of transrectal ultrasound or TRUS devices in Asia Pacific is one of the major factors driving the market. An rising need to replace existing healthcare infrastructure in Asia Pacific is another factor driving the market. North America held a considerable share in the global market in 2017. High diagnostic rates of benign prostatic hyperplasia, rising prevalence of urological disorders, and robust healthcare infrastructure contributed towards the growth of this region. The demand for transrectal ultrasound procedures in Europe is also expected to rise steadily during the forecast period mainly on account of rising geriatric population and demand for minimally invasive devices.

Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/sample/transrectal-ultrasound-trus-market-100137

Major Transrectal Ultrasound Manufacturers covered in the market report include:

• GE Healthcare
• BK Medical Holding Company, Inc.
• KOELIS
• Exact Imaging
• The Prometheus Group
• TELEMED
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Lifestyle Changes Leading to Rising Prevalence of Prostate Cancer in turn Fueling Demand for TRUS Devices

“The demand for effective treatment for urological abnormalities such as prostate cancer is increasing primarily due to rapid changes in lifestyle,” stated a lead analyst at Fortune Business Insights. “This is one of the chief factors driving the Transrectal Ultrasound Market,” he added. The transrectal ultrasound of prostate helps to locate the position of cysts in the male reproductive system and identify if they are cancerous or non-cancerous. This is the reason why male population prefers transrectal ultrasound scan than any other normal tests. The healthcare infrastructure in developed and developing countries is sophisticated and well-equipped. This, coupled with better product availability, is boosting the market.

There are several other factors spelling growth in the market. Governments across regions are actively participating to ensure the early detection and timely treatment of prostate cancer. This factor, combined with technological developments, is anticipated to bode well for the market.

Transrectal ultrasound or endorectal ultrasound uses different technologies to get accurate and precise test results. These technologies include 2D, 3D technology, and others such as real-time imaging. The advent of such technologies is projected to further drive in the coming years. The adoption of Transrectal Ultrasound devices is likely to increase in hospitals, clinics, diagnostic centers, and surgical centers. This will encourage companies to introduce novel TRUS devices with the help of upcoming technologies.

Quick Buy Transrectal Ultrasound Market

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

The current pandemic of Covid-19 has made a catastrophic impact on the world. Most businesses are shut as a result of the increasing COVID-19 cases. The healthcare industry is facing shortage of medical aid as there are not enough beds to suffice the needs of the increasing number of patients. The world economy is fluctuating as most businesses are at a halt and the ones running from the vicinity of their homes are barely able to manage revenue.

Special reports on various markets affected by the coronavirus pandemic are provided by Fortune Business Insights. These reports will help visualize the current situation and what strategies can be adopted to help the market gain momentum in the coming years.

Stringent Healthcare Policies by Regulatory Authorities may Inhibit Growth

Despite witnessing strong growth prospects, there are certain factors that may restrict the market in the coming years. Strict regulations regarding approvals on healthcare medications and diagnosis may inhibit the growth of the market. In addition to this, product recalls due to safety issues may restrict the market to grow in the next coming years. Nonetheless, several companies are planning to invest in R&D activities and technological developments, which will propel growth in the market.

Several Savvy Players to Launch Advanced TRUS Devices; Helping Market to Pick Pace

The competitive landscape of global market is semi-consolidated. The market was dominated by some well recognized brands in 2017. B.K. Holding was one of them, which covered a significant share in the global market for TRUS. Some of the other companies presently functioning in the global market are TELEMED, Esaote SpA, GE Healthcare, The Prometheus Group, and Exact Imaging.

Have Any Query? Ask Our Experts

The global Transrectal Ultrasound Market can be segmented into the following categories:

• By Product
  • Devices
  • Transducers

• By Type
  • Cart/ Trolley-based
  • Portable

• By Application
  • Diagnostic
    • Prostate Cancer
    • Benign Prostatic Hyperplasia
    • Others
  • Image-guided Treatment

• By End User
  • Diagnostic Laboratories
  • Hospitals
  • Others

• By Region
  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Spain, Scandinavia, Rest of Europe)
  • Asia Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)

Related Report

Blood Screening Market Revenue

Blood Screening Market Manufacturers

Blood Screening Market Size

Blood Screening Market Covid Effect

Blood Screening Market Condition

Blood Screening Market Impact

Blood Screening Market Impact

Blood Screening Market Shares

Blood Screening Market Trends

Blood Screening Market Drivers

Blood Screening Market Increase

Blood Screening Market Rise

Continuous Renal Replacement Therapy Market CAGR Value

Continuous Renal Replacement Therapy Market Covid Effect

Continuous Renal Replacement Therapy Market Condition

Continuous Renal Replacement Therapy Market Search Analysis

Continuous Renal Replacement Therapy Market Growth Analysis

The Global Robotic Surgical Procedures Market is anticipated to reach USD 13271.6 Mn by 2025 as per a report published by Fortune Business Insights. According to the report, titled “Robotic Surgical Procedures Market Size, Share and Global Trend By Product Type (Gynecology, Urology, General Surgery, Orthopedics and Others) and Geography Forecast till 2025,” the market covered a value of USD 3912.2 Mn in the year 2017.

Furthermore, growing preference for minimally-invasive surgical procedures is expected to encourage the global market exhibit a remarkable CAGR of 16.6% by 2025. The report also mentioned that technological developments in surgical robots will propel growth of the market.

Sample PDF Brochure :

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/robotic-surgical-procedures-market-100124

KEY COMPANIES MENTIONED IN REPORT

• Intuitive Surgical, Inc.
• Zimmer Biomet
• Stryker Corporation
• Medtronic
• Smith & Nephew
• Accuray Incorporated
• CMR Surgical Ltd.
• Avatera Medical GmbH
• sVerb Surgical Inc.
• Other players

Gynaecology Emerges as Most Preferred Area in Robotic Surgical Procedures

The gynaecology segment is likely to gain significant momentum and lead the global market over the forecast years. Fortune Business Insights reports that this segment covered a share of 28.7% and is expected to account for the highest share in the market by 2025. The report observed that this segment is leading on account of an extensive use of robotic-assisted surgical procedures in the healthcare sector. Besides gynaecology, the orthopaedics segment is also projected to grow at a higher CAGR in the forecast years. This is ascribable to the rising number of product innovations in orthopaedics area. Presently, the number of orthopaedic surgeries conducted via robotic surgical machines is very low. With the rising incidence of bone injuries, the number is expected to increase in the coming years.

Asia Pacific to Upscale its Operations with Majority of the Revenue Generated from China and India

North America is anticipated to remain dominant till 2025 in the global robotic surgical procedure market. The market in this region was worth US$ 3070.7 Mn in the year 2017 and it is likely to grow with the increasing adoption of robotic surgical instruments and systems. The penetration of robotics is higher in the countries of North America than other regions. This is likely to create growth opportunities for the market in the forthcoming years. The market in Asia Pacific is also expected to grow with the increasing adoption of robotic surgical systems especially in China and India. The region’s growth is also attributable to increasing western partnerships so as to enhance healthcare facilities. In addition to this, governments are expected to collaborate with regional institutions to develop surgical robots.

Major Table of Content Robotic Surgical Procedures Market;

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary
3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/robotic-surgical-procedures-market-100124

Increasing Need for Automation in Healthcare to Influence Overall Growth

“The healthcare industry is transforming with the introduction of technological developments such as 3D imaging sensors, microscopic cameras, and robotic surgical instruments,” says a lead analyst at Fortune Business Insights. “This is further expected to enhance surgical outcomes and drive the market over the next few years,” he added. Automation is emerging in healthcare industry as it reduces the requirement for human work and optimizes clinical outcomes. It is further expected to improve operational efficiency and reduce cost, thus boosting the market. The introduction of new and economical surgical robots in developed and developing countries stimulate growth in the market. Hospitals across the world are likely to adopt robotic surgical equipment in the coming years, which in turn, may offer tailwinds to the market.

Mounting Costs of Robotic Surgeries May Impede the Growth

Some countries are not able to afford the high costs associate with robotic surgical procedures. The high cost involved in robotic systems may therefore restrict the market’s growth. In addition to this, increasing cases of mortality while conducting robotic surgeries pose a serious threat to the market in the coming years. Be it as it may, some of the developing economies such as China, India, and Brazil are expected to create impressive growth opportunities in the market by 2025.

 Intuitive Surgical Inc. Emerges Dominant at a Global Scale

The robotic surgical procedures market is likely to be dominated by Intuitive Surgical Inc. as per revenue. In 2017, the company was leading with more than half of the share in the global market. This is primarily on account of high installed base in countries such as the U.S. and some countries in Europe. Furthermore, the company’s Da Vinci family of robotic surgical systems is continuously receiving approvals regarding new areas of application. Another leading company in the market is Stryker owing to its acquisition of another company called MAKO Surgical Corp. in the year 2013. Some of the other leading companies operating in the global market include Medtronic, Zimmer Biomet, Accuray Incorporated, Smith & Nephew, CMR Surgical Ltd., Verb Surgical Inc., and Avatera Medical GmbH.

Related Reports:

Continuous Renal Replacement Therapy Market Revenue

Continuous Renal Replacement Therapy Market Manufacturers

Continuous Renal Replacement Therapy Market Drivers

Continuous Renal Replacement Therapy Market Drivers

Continuous Renal Replacement Therapy Market Research Methodology

Continuous Renal Replacement Therapy Market Future Growth

Continuous Renal Replacement Therapy Market Devlopment Strategy

Ophthalmic Diagnostic Devices Market Industry

Ophthalmic Diagnostic Devices Market Overview

Ophthalmic Diagnostic Devices Market Segments

Ophthalmic Diagnostic Devices Market Competitive Landscape

Ophthalmic Diagnostic Devices Market Demand

Ophthalmic Diagnostic Devices Market Key Players

Ophthalmic Diagnostic Devices Market Business Opportunities

Ophthalmic Diagnostic Devices Market Analysis

Ophthalmic Diagnostic Devices Market Growth

Ophthalmic Diagnostic Devices Market Trends

Ophthalmic Diagnostic Devices Market Share

Ophthalmic Diagnostic Devices Market Size

Exhibiting a high prevalence for rheumatoid arthritis, North America is forecast to lead the global “rheumatoid arthritis therapeutics market” in a recent report. In a report, titled “RHEUMATOID ARTHRITIS THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2018-2025”, Fortune Business Insights identifies numerous factors enabling growth in the market. According to the report, the global rheumatoid arthritis therapeutics market is anticipated to exhibit 4.6% CAGR and reach valuation of US$ 33,958.4 Mn in 2025 from US$ 23,822.5 Mn in 2017.

Request a Sample Copy of the Research Report

North America to Lead Global Market with Rising Prevalence of Rheumatoid Arthritis

The North America market was worth US$ 9,929.6 Mn in 2017. It is expected to show steady rise owing to the rising prevalence of rheumatoid arthritis and increasing awareness about this disorder. Adding to that, governments of North America are investing huge sums for improving the healthcare and medical facilities in the region.

This is helping the rheumatoid arthritis therapeutics market to grow at an impressive pace in North America.On the other side, the demand for rheumatoid arthritis treatment is likely to grow at a considerable pace in Asia Pacific. This is owing to the entry of new drugs, especially biologics, for the treatment of rheumatoid arthritis in the market. This, coupled with expansion of healthcare and medical infrastructure in emerging nations, is likely to help rheumatoid arthritis therapeutic market in Asia Pacific gain more momentum.

Quick Buy Rheumatoid Arthritis Therapeutics Market

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Biologics Segment to Account for Highest Market Share

In terms of product type, the biologics segment is anticipated to hold the highest share in the market in terms of revenue during the forecast period. In 2017, the biologics segment held 87.6% of the rheumatoid arthritis therapeutics market. This is because biologics targeting specific components of the immune response system help to slow down the rate of progression of arthritis in the patient. They also help in improving the physical functionality of patients and are cost efficient as compared to other treatment methods, which helps to increase the demand for biologics in the market.

Presence of expensive drugs for rheumatoid arthritis treatment, coupled with, favorable reimbursement policies are factors propelling the global market. Developing countries are making efforts to improve their medical infrastructure in order to provide medical aid for diseases such as chronic arthritis and other chronic diseases and this is another key factor helping the market to grow.

Increasing Number of Medical Professionals Facilitating Rheumatoid Arthritis Treatment

Rise in geriatric population is a key factor enabling growth in the market. The prevalence of arthritis is considerably high among aged population, which is why a rise in their number is expected to bode well for the overall market. In case of rheumatoid arthritis, improvement in diagnostic procedures is favoring growth of the global market for rheumatoid arthritis. Furthermore, the market is expected to gain from the spread of various awareness programs and increasing number of skilled healthcare professionals.

In 2017, AbbVie Inc., emerged dominant in the global rheumatoid arthritis therapeutics market. At present there are numerous market players operating in the market, out of which about ten players hold 80% of the market. In order to gain competitive advantage, some of the leading companies are focusing on investing increasingly towards research and development of novel therapeutics. Some of the other key players operating in the global rheumatoid arthritis therapeutics market are

• Gilead Sciences, Inc.
• Hoffmann-La Roche AG
• Eli Lilly and Company
• UCB S.A.
• Bristol-Myers Squibb Company
• Amgen Inc., Pfizer Inc.
• Celgene Corporation
• Johnson & Johnson Services, Inc.

Have Any Query? Ask Our Experts

Related Reports:

Prothrombin Complex Concentrate MarketMarket Share

Healthcare Architecture MarketMarket Size

ePharmacy Market

The global “kidney stone management market” size is expected to rise prominently on account of the increasing cases of kidney stone among people worldwide. This is further attributed to the formation of crystal-like substances such as uric acid, oxalate, and calcium which cannot be diluted in the urine as a result of consuming food and drinks that are rich in phosphate and oxalate. A recent report by Fortune Business Insights, titled, “Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy (PCNL) By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Regional Forecast, 2020-2027,” states that the market was valued at USD 1.47 billion in 2019 and is anticipated to rise at a CAGR of 5.3% to reach USD 2.21 billion by the end of 2027.

Currently, the COVID-19 pandemic has brought about many devastating effects on both human life and the world economy. Lockdown is followed globally and this has impacted most businesses, both on national and international levels. However, we hope to overcome this panic phase soon and things would get back to normal with support from the government. We, at Fortune Business Insights, are offering special reports on various markets that have exhibited a significant impact owing to the coronavirus.

Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/sample/kidney-stone-management-devices-market-100450

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Quick Buy Kidney Stone Management Market

The Report Answers the Following Questions:

• How fierce is the kidney stone treatment devices market competition?
• Who are the major players and what are their blueprints?
• Which innovations will add impetus to the urolithiasis management market?
• Which are the recent industry developments of the market?

Segment:

Ureteroscopy Segment to Draw Maximum Share Owing to its Low Recurrence Rates

Based on segmentation by type, the ureteroscopy segment earned 51.51% kidney stone management market share and emerged dominant. This is because it treats those stones that are invisible on an x-ray machine, followed by its high success and low recurrence rates, thereby aiding to the expansion of the overall urolithiasis management market.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/kidney-stone-management-devices-market-100450

Related Reports:

Prothrombin Complex Concentrate Market Manufacturers

Prothrombin Complex Concentrate Market Drivers

Prothrombin Complex Concentrate Market Drivers

Prothrombin Complex Concentrate Market Research Methodology

Prothrombin Complex Concentrate Market Future Growth

Prothrombin Complex Concentrate Market Devlopment Strategy

Prothrombin Complex Concentrate Market Industry

Prothrombin Complex Concentrate Market Overview

Prothrombin Complex Concentrate Market Segments

Prothrombin Complex Concentrate Market Competitive Landscape

Prothrombin Complex Concentrate Market Demand

Prothrombin Complex Concentrate Market Key Players

Prothrombin Complex Concentrate Market Business Opportunities

Prothrombin Complex Concentrate Market Analysis

Prothrombin Complex Concentrate Market Growth

Prothrombin Complex Concentrate Market Trends

Prothrombin Complex Concentrate Market Share

Prothrombin Complex Concentrate Market Size

The global prothrombin complex concentrate (PCC) size is poised to reach USD 1,076.5 million by 2025, registering a CAGR of 9.1% during the forecast period. Rising prevalence of hemophilia across the globe is expected to be a major growth driver for this market. Hemophilia is a rare blood disorder wherein normal blood clotting does not occur due to absence or insufficient amount of clotting proteins in the individual’s blood. Though rare, the disorder has been found to have increased in prevalence. According to a study led by Canada’s McMaster University, more than 1,125,000 men worldwide suffer from this inherited affliction. PCC treatments have been found to be highly effective in managing hemophilia, a study published in JAMA Pediatrics, a peer-reviewed medical journal, found. This bodes well for the prothrombin complex concentrate market growth as adoption rate of PCC therapeutics picks up pace.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/prothrombin-complex-concentrate-pcc-market-100102

According to the Fortune Business Insights report, titled “Prothrombin Complex Concentrate (PCC) Market Size, Share and Industry Analysis By Product Type (3-factor PCC, 4-factor PCC), By Application (Congenital and Acquired Coagulation Factor deficiency), By End User (Hospitals, Ambulatory Surgical Centers), and Regional Forecast 2018-2025”, the market value stood at USD 536.3 million in 2017. The report also contains a bird’s eye-view analysis of the overall industry outlook and a worm’s eye-view assessment of the various factors, future prospects, upcoming trends, regional dynamics, and competitive landscape that will shape the market in the forecast period.

Derived from human plasma, prothrombin complex concentrate (PCC) is a specialized medication therapy comprising of different blood clotting factors. It is primarily utilized to treat haemophilia B. Recognized as a safe and effective medication, PCC is part of WHO’s List of Essential Medicines.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prothrombin-complex-concentrate-pcc-market-100102

Growing Utilization of 4-Factor PCC to Boost Sales

The 4-factor prothrombin complex concentrate (4F-PCC) is used to expedite the reversal of vitamin K antagonist (VKA). It carries several benefits which is fuelling its popularity. For example, this PCC variant contains coagulation factor VII, which is not present in other variants. Furthermore, administering 4F-PCC is relatively easy as it requires a reduced infusion volume and it also minimizes the risk of pathogen transmission. Effectivity of its treatment mechanism has surged its adoption rate and given it international recognition. For instance, the British Committee for Standards in Haematology has prescribed specific guidelines for the deployment of PCC techniques in treating haemophiliacs. These developments are expected to provide a positive thrust to the market for this medication technology.

 Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/prothrombin-complex-concentrate-pcc-market-100102

Asia-Pacific to Boast a High CAGR; North America to Dominate

With a revenue generation of USD 210.2 million in 2017, North America is set to lead the global prothrombin complex concentrates market share in the forecast period. This is mainly owing to the presence of major players in the region. Evolving health insurance policies for rare blood disorders and increase in the number of plasma collection centres in India and China will enable Asia-Pacific to grow at an impressive CAGR till 2025. In Europe, the market will be driven by the rising prevalence of congenital coagulation factors deficiency.

Operational Diversification by Players to Intensify Competition

According to the prothrombin complex concentrate market trends, key players are adopting strategies to expand, disperse, and diversify their operational reach with a view to strengthen their position in the PCC market. This is being accomplished through partnerships with other companies and acquisition activities.

Key industry developments:

• June 2017: The Chinese plasma fractionator, Wuhan Zhong Yuan Rui De Biological, was acquired by CSL Behring to establish CSL’s presence in the plasma fractionation market in China. This move was further vindicated when CSL’s PCC brand, Kcentra, got cleared for commercial release in Japan.
• August 2018: Grifols S.A. took over 24 plasma donation centres in the US, thereby strengthening its supply of plasma proteins for blood disorder treatments.

Fortune Business Insights identifies the following players in the PCC market:

• Sanquin
• China Biologic Products Holdings, Inc.
• Grifols SA
• Shire
• Octapharma AG
• Kedrion S.p.A
• CSL BehringRelated Reports:

  Healthcare Architecture Market Manufacturers

  Healthcare Architecture Market Drivers

  Healthcare Architecture Market Drivers

  Healthcare Architecture Market Research Methodology

  Healthcare Architecture Market Future Growth

  Healthcare Architecture Market Devlopment Strategy

  Healthcare Architecture Market Industry

  Healthcare Architecture Market Overview

  Healthcare Architecture Market Segments

  Healthcare Architecture Market Competitive Landscape

  Healthcare Architecture Market Demand

  Healthcare Architecture Market Demand

  Healthcare Architecture Market Business Opportunities

  Healthcare Architecture Market Analysis

  Healthcare Architecture Market Growth

  Healthcare Architecture Market Trends

  Healthcare Architecture Market Share

  Healthcare Architecture Market Size